Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Mild behavioral impairment: a new clinical marker for Alzheimer’s disease?

Byron Creese, PhD, University of Exeter Medical School, Exeter, UK, explains mild behavioral impairment, which consists of late-life onset, sustained, neuropsychiatric symptoms that can occur alongside or independently of mild cognitive impairment (MCI). The presence of these symptoms often means a faster progression to dementia. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.